Rothfuss Cristin 4
4 · Sarepta Therapeutics, Inc. · Filed Nov 29, 2024
Insider Transaction Report
Form 4
Rothfuss Cristin
EVP, General Counsel
Transactions
- Award
Stock Option (right to buy)
2024-11-26+4,000→ 4,000 totalExercise: $130.50From: 2025-11-26Exp: 2034-11-26→ Common Stock (4,000 underlying) - Award
Common Stock
2024-11-26+2,000→ 13,817 total
Footnotes (2)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
- [F2]Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.